President Trump Reportedly Has Shares In Possible COVID-19 Cure

Publish date:

President Trump reportedly has a "small personal financial interest" in Sanofi, a French drugmaker that produces hydroxychloroquine -- an anti-malaria drug that Trump has repeatedly touted as the cure for coronavirus.

Trump has claimed that the drug can prevent contracting the virus -- but experts are not sure. There is no evidence that hydroxychloroquine prevents getting infected by coronavirus.

"They say taking it before the fact is good, but what do you have to lose?" Trump told reporters. "They say take it. I'm not looking at it one way or the other, but we want to get out of this. If it does work, it would be a shame if we didn't do it early. But we have some very good signs," he said without naming any source at all.

Sanofi produces Plaquenil, the brand-name form of hydroxychloroquine, the New York Times reports; the drug is typically used to treat rheumatoid arthritis, lupus and malaria. Forbes has Trump's stake in the company at just $3,000 -- but other Republican donors also have shares in the company.